Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 -0.32%94 ROC (Joel Greenblatt) % is 16.23% as of Mar. 2026, which is 23% below its 10-year median of 21.16. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,408.03 (Fairly Valued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks better than 61.26% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Dr Agarwal'S Eye Hospital's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.23%.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:526783'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 15.69 Med: 21.16 Max: 50.3
Current: 19.59
During the past 13 years, Dr Agarwal'S Eye Hospital's highest ROC (Joel Greenblatt) % was 50.30%. The lowest was 15.69%. And the median was 21.16%.
BOM:526783's ROC (Joel Greenblatt) % is ranked better than 61.26% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 12.485
vs BOM:526783: 19.59
Dr Agarwal'S Eye Hospital's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 1.10% per year.
Dr Agarwal'S Eye Hospital (BOM:526783) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Dr Agarwal'S Eye Hospital ROC (Joel Greenblatt) % Related Terms
Dr Agarwal'S Eye Hospital ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital ROC (Joel Greenblatt) % Chart
BOM:526783 vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % falls into.
Dr Agarwal'S Eye Hospital ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 16.23% mean?
Dr Agarwal'S Eye Hospital (BOM:526783) has a ROC (Joel Greenblatt) % of 16.23% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 23% below median its historical median of 21.16. Over the past decade, Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % has ranged from 15.69 to 50.30. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #258 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 38.7%.
Is Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % too high?
Dr Agarwal'S Eye Hospital's current ROC (Joel Greenblatt) % of 16.23% is 23% below median its 10-year median of 21.16. Over the past 10 years, this metric has ranged from a low of 15.69 to a high of 50.30. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Dr Agarwal'S Eye Hospital's value of 16.23% is 30% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #258 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #258 out of 666 companies for ROC (Joel Greenblatt) %. This puts Dr Agarwal'S Eye Hospital in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.49. Dr Agarwal'S Eye Hospital's value of 16.23% is 30% above this benchmark. Historically, Dr Agarwal'S Eye Hospital's own ROC (Joel Greenblatt) % has ranged from 15.69 to 50.30 over the past decade. While the company's 10-year median is 21.16 vs. the industry median of 12.49, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current ROC (Joel Greenblatt) % of 16.23% is 30% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current ROC (Joel Greenblatt) % is 16.23%, which is 23% below median its own 10-year median of 21.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,408.03, compared to a current price of ₹5,016.60 — trading 7.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 16.23%, which is 23% below median its 10-year median of 21.16 and 30% above the Healthcare Providers & Services industry median of 12.49. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current ROC (Joel Greenblatt) % is 16.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,016.60 is trading 7.2% below its estimated GF Value™ of ₹5,408.03.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
ROC (Joel Greenblatt) %: 16.23% (23% below median its 10-year median of 21.16)
GF Value™: ₹5,408.03 vs. price of ₹5,016.60 (7.2% below fair value)
Industry Position: 30% above the Healthcare Providers & Services median (#258 of 666)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
